Retatrutide, Eli Lillys latest weight management and diabetes drug, appears to have outperformed the companys current product, tirzepatide (Mounjaro, Zepbound), in clinical trials
Two people with identical body composition can therefore respond very differently
Further adjustments may be made based on individual patient needs and response to treatment
How prescription GLP-1 treatments really work Weight loss injections, such as Wegovy, Mounjaro, and Nevolat, are clinically proven and effective medications
They may advise you to take a supplemental dose, wait until your next scheduled injection, or adjust your schedule
Cagrilintides focused amylin receptor targeting may offer regulatory advantages through its more predictable mechanism and potentially favourable safety profile